Kuneš J - Search Results

1

Nontoxic combretafuranone analogues with high in vitro antibacterial activity.

Horký P, Voráčová M, Konečná K, Sedlák D, Bartůněk P, Vacek J, Kuneš J, Pour M. Horký P, et al. Among authors: kunes j. Eur J Med Chem. 2018 Jan 1;143:843-853. doi: 10.1016/j.ejmech.2017.11.078. Epub 2017 Nov 29. Eur J Med Chem. 2018. PMID: 29223099

2

3-Phenyl-5-methyl-2H,5H-furan-2-ones: tuning antifungal activity by varying substituents on the phenyl ring.

Pour M, Spulák M, Balsánek V, Kunes J, Buchta V, Waisser K. Pour M, et al. Among authors: kunes j. Bioorg Med Chem Lett. 2000 Aug 21;10(16):1893-5. doi: 10.1016/s0960-894x(00)00376-0. Bioorg Med Chem Lett. 2000. PMID: 10969993

3

Quinazoline derivatives with antitubercular activity.

Kunes J, Bazant J, Pour M, Waisser K, Slosárek M, Janota J. Kunes J, et al. Farmaco. 2000 Nov-Dec;55(11-12):725-9. doi: 10.1016/s0014-827x(00)00100-2. Farmaco. 2000. PMID: 11204949

4

Antimycobacterial and antifungal isosters of salicylamides.

Waisser K, Pesina M, Holý P, Pour M, Bures O, Kunes J, Klimesová V, Buchta V, Kubanová P, Kaustová J. Waisser K, et al. Among authors: kunes j. Arch Pharm (Weinheim). 2003 Aug;336(6-7):322-35. doi: 10.1002/ardp.200300725. Arch Pharm (Weinheim). 2003. PMID: 12953220

5

Antimycobacterial 3-aryl-2H-1,3-benzoxazine-2,4(3H)-diones.

Waisser K, Bures O, Holý P, Kunes J, Oswald R, Jirásková L, Pour M, Klimesová V, Palát K Jr, Kaustová J, Danse HM, Möllmann U. Waisser K, et al. Among authors: kunes j. Pharmazie. 2003 Feb;58(2):83-94. Pharmazie. 2003. PMID: 12641321

6

New groups of antimycobacterial agents: 6-chloro-3-phenyl-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 6-chloro-3-phenyl-2H-1,3-benzoxazine-2,4(3H)-dithiones.

Waisser K, Gregor J, Kubicová L, Klimesová V, Kunes J, Machácek M, Kaustová J. Waisser K, et al. Among authors: kunes j. Eur J Med Chem. 2000 Jul-Aug;35(7-8):733-41. doi: 10.1016/s0223-5234(00)00174-4. Eur J Med Chem. 2000. PMID: 10960190

7

Disposition study of a new potential antineoplastic agent dimefluron in rats using high-performance liquid chromatography with ultraviolet and mass spectrometric detection.

Císar P, Nobilis M, Vybíralová Z, Holcapek M, Kolárová L, Pour M, Kunes J, Klimes J. Císar P, et al. Among authors: kunes j. J Pharm Biomed Anal. 2005 Apr 29;37(5):1059-71. doi: 10.1016/j.jpba.2004.09.031. J Pharm Biomed Anal. 2005. PMID: 15862686

8

High-performance liquid chromatographic determination of ursodeoxycholic acid after solid phase extraction of blood serum and detection-oriented derivatization.

Nobilis M, Pour M, Kunes J, Kopecký J, Kvĕtina J, Svoboda Z, Sládková K, Vortel J. Nobilis M, et al. Among authors: kunes j. J Pharm Biomed Anal. 2001 Mar;24(5-6):937-46. doi: 10.1016/s0731-7085(00)00563-x. J Pharm Biomed Anal. 2001. PMID: 11248487

9

High-performance liquid chromatographic determination of tramadol and its O-desmethylated metabolite in blood plasma. Application to a bioequivalence study in humans.

Nobilis M, Kopecký J, Kvetina J, Chládek J, Svoboda Z, Vorísek V, Perlík F, Pour M, Kunes J. Nobilis M, et al. Among authors: kunes j. J Chromatogr A. 2002 Mar 8;949(1-2):11-22. doi: 10.1016/s0021-9673(01)01567-9. J Chromatogr A. 2002. PMID: 11999728

10

Comparative biotransformation and disposition studies of nabumetone in humans and minipigs using high-performance liquid chromatography with ultraviolet, fluorescence and mass spectrometric detection.

Nobilis M, Kopecký J, Kvetina J, Svoboda Z, Pour M, Kunes J, Holcapek M, Kolárová L. Nobilis M, et al. Among authors: kunes j. J Pharm Biomed Anal. 2003 Aug 8;32(4-5):641-56. doi: 10.1016/s0731-7085(03)00171-7. J Pharm Biomed Anal. 2003. PMID: 12899954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

425 results

Search Page